Prognostic Factors for Endometrial and Cervical Cancers of Uterus Treated With Immune-cell Therapy: A Retrospective Study | Anticancer Research
Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer: Molecular Therapy - Nucleic Acids
Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis | BMC Cancer | Full Text
NEJM on X: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months
Kaplan-Meier estimates of overall survival. The three groups are:... | Download Scientific Diagram
A) Recurrence-free survival, (B) disease-specific survival and (C)... | Download Scientific Diagram
Cancers | Free Full-Text | Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?
Endometrial cancer among a cohort of urban Haitian immigrants
A clinically applicable molecular-based classification for endometrial cancers | British Journal of Cancer
Endometrial cancer - Wikipedia
Overall survival in endometrial cancer patients according to histologic... | Download Scientific Diagram
Kaplan-Meier plot of Overall Survival (OS) in advanced endometrial... | Download Scientific Diagram
Recurrence and survival of patients with stage III endometrial cancer after radical surgery followed by adjuvant chemo- or chemoradiotherapy: a systematic review and meta-analysis | BMC Cancer | Full Text
Expanded Role for Immunotherapy to Treat Endometrial Cancer - NCI
Endometrial Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
Natural history of recurrences in endometrial carcinoma
Frontiers | Endometrial Cancer Type 2 Incidence and Survival Disparities Within Subsets of the US Black Population
Endometrial Cancer Treatment (PDQ®) - NCI
Patterns of failure after adjuvant “sandwich” chemo-radio-chemotherapy in locally advanced (stage III–IVA) endometrial cancer | SpringerLink
a Endometrial cancer-related survival by 4 molecular subgroups in the... | Download Scientific Diagram
Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival | British Journal of Cancer
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series - ScienceDirect
Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion | International Journal of Gynecologic Cancer
Cancers | Free Full-Text | Recurrent Endometrial Cancer: Local and Systemic Treatment Options
Cancers | Free Full-Text | Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis - Gynecologic Oncology
